NRX Pharmaceuticals Inc

NASDAQ:NRXP

2.32

-0.20 (-7.94%)

7:54:43 PM EDT: $2.34 +0.02 (+0.86%)

Market Cap (Intraday)	50.77M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	0.99

See more stats

Estimates Current Quarter

Revenue	$7 Million
Adjusted EPS	$0.04

See more estimates

10-Day MA	$2.55
50-Day MA	$2.90
200-Day MA	$2.47

See more pivots

NRX Pharmaceuticals Inc Stock, NASDAQ:NRXP

1201 Orange Street, Suite 600, Wilmington, Delaware 19801

United States of America

Phone: +1.484.254.6134

Number of Employees:

http://www.nrxpharma.com

Description

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.